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Accompanying Videos S1 and S2 are available at <http://jaha.ahajournals.org/content/5/1/e002508/suppl/DC1>

Introduction {#jah31268-sec-0004}
============

Cardiac outflow tract (OFT) defects account for approximately one‐third of all congenital heart defects (CHDs) reported in humans births and often require intervention within the first year of life. Even after surgical correction, risk of morbidity and mortality from OFT defects remains high.[1](#jah31268-bib-0001){ref-type="ref"}, [2](#jah31268-bib-0002){ref-type="ref"} Nevertheless, the molecular mechanisms underlying OFT defects are not well defined. Understanding the developmental mechanisms of OFT formation is crucial for new insights into improving diagnostics and designing therapeutic approaches for CHD patients.

Cell polarity is the asymmetrical organization of cell membrane proteins, intracellular organelles, and actin cytoskeleton that can influence cell fate and specialized functions such as migration and proliferation.[3](#jah31268-bib-0003){ref-type="ref"} Establishment of polarity is a critical step in a multitude of developmental events, including formation of the OFT.[4](#jah31268-bib-0004){ref-type="ref"}, [5](#jah31268-bib-0005){ref-type="ref"} The intricate process of OFT development involves coordination and interactions between 2 distinct cell types, second heart field (SHF) progenitors and cardiac neural crest cells.[6](#jah31268-bib-0006){ref-type="ref"} The SHF progenitors give rise to the myocardial and endothelial cells of the OFT, semilunar valves, along with vascular smooth muscle cells at the base of the aorta and pulmonary trunk. Neural crest cells contribute to septation of the OFT and remodeling of the aortic arches and semilunar valves.[7](#jah31268-bib-0007){ref-type="ref"}, [8](#jah31268-bib-0008){ref-type="ref"} At approximately embryonic day 8.5 (E8.5), cardiac neural crest cells will delaminate from the neural tube, migrate into the pharyngeal region, and become closely apposed with SHF progenitors in the dorsal pericardial wall.[9](#jah31268-bib-0009){ref-type="ref"} SHF cells form an apicobasally polarized epithelium in the splanchnic mesoderm, and maintenance of this apicobasal polarity is crucial for heart tube elongation and OFT morphogenesis.[10](#jah31268-bib-0010){ref-type="ref"} Planar cell polarity, which is orthogonal to apicobasal polarity, has also been shown to be a critical regulator of the SHF because tissue‐specific deletion of core planar cell polarity genes *Vangl2* and *Dishevelled1/2* recapitulates the spectrum of OFT defects reported in the full‐body mutants.[11](#jah31268-bib-0011){ref-type="ref"}, [12](#jah31268-bib-0012){ref-type="ref"} Recent studies have suggested that apicobasal polarity and planar cell polarity signaling are interconnected where crosstalk occurs to maintain cellular polarity and overall tissue architecture.[13](#jah31268-bib-0013){ref-type="ref"}, [14](#jah31268-bib-0014){ref-type="ref"}

Rac1 is a small signaling GTPase from the Rac subfamily of Rho GTPases and has been implicated in both apicobasal polarity and planar cell polarity signaling pathways.[15](#jah31268-bib-0015){ref-type="ref"}, [16](#jah31268-bib-0016){ref-type="ref"} Rac1 acts as a pleiotropic effector of numerous cellular processes including regulation of the actin cytoskeleton and overall cell shape and morphology, which are critical components of cell polarity.[17](#jah31268-bib-0017){ref-type="ref"} The role of Rac1 in cell polarity has been shown by orientation of hair cells in the cochlea, convergent extension cellular movements, and anterior--posterior body axis specification during development.[18](#jah31268-bib-0018){ref-type="ref"}, [19](#jah31268-bib-0019){ref-type="ref"}, [20](#jah31268-bib-0020){ref-type="ref"} We recently demonstrated Rac1 to be a critical regulator of cardiomyocyte polarity and cardiac septation during heart development[21](#jah31268-bib-0021){ref-type="ref"}; however, the role of Rac1 in OFT development is unknown. The SHF progenitors in the dorsal splanchnic mesoderm can be further subdivided into 2 subdomains: the anterior and the posterior SHF.[22](#jah31268-bib-0022){ref-type="ref"}, [23](#jah31268-bib-0023){ref-type="ref"} A *Mef2c‐Cre* transgenic mouse has been developed that drives expression of Cre recombinase solely in the anterior subdomain of the SHF, which contributes to the right ventricle and the OFT. Specifically, the Cre recombinase sequence in the *Mef2c‐Cre* transgenic mouse is under regulatory control of an anterior heart field--specific enhancer and promoter, which was first discovered by Dodou et al.[8](#jah31268-bib-0008){ref-type="ref"}, [24](#jah31268-bib-0024){ref-type="ref"} To study the role of Rac1 in OFT formation, we generated an anterior SHF‐specific deletion of *Rac1* using the *Mef2c‐Cre* transgenic mouse, as described previously.[21](#jah31268-bib-0021){ref-type="ref"} We showed that Rac1 signaling in the anterior SHF is critical for progenitor cellular organization in the splanchnic mesoderm and that disruptions in Rac1 signaling result in a spectrum of OFT defects, along with aortic valve defects. Furthermore, we showed that a Rac1 deficiency restricted to the anterior SHF leads to neural crest cell migration defects.

Methods {#jah31268-sec-0005}
=======

Mice {#jah31268-sec-0006}
----

*Rac1* ^*f/f*^ (stock 5550) and *mT/mG* mice (stock 7676) were purchased from Jackson Laboratory (Bar Harbor, ME).[25](#jah31268-bib-0025){ref-type="ref"}, [26](#jah31268-bib-0026){ref-type="ref"} The anterior SHF‐specific *Mef2c‐Cre* transgenic mice were rederived from embryos obtained from the Mutant Mouse Regional Resource Centers (Chapel Hill, NC).[8](#jah31268-bib-0008){ref-type="ref"} A breeding program to generate *Mef2c‐Cre;Rac1* ^*f/f*^ (*Rac1* ^*SHF*^) mice was carried out and genotyping was performed, as described previously.[21](#jah31268-bib-0021){ref-type="ref"} All mouse experiments and procedures were approved by the animal use subcommittee at the University of Western Ontario in accordance with the guidelines of the Canadian Council of Animal Care.

Fate Mapping Analysis {#jah31268-sec-0007}
---------------------

Fate mapping analysis was performed using *Mef2c‐Cre* and the *mT/mG* global double‐fluorescent Cre reporter mice to trace the anterior SHF and derivatives.[8](#jah31268-bib-0008){ref-type="ref"}, [26](#jah31268-bib-0026){ref-type="ref"} A breeding strategy was carried out to generate *Mef2c‐Cre;mT/mG* and *Mef2c‐Cre;Rac1* ^*f/f*^ *;mT/mG* (*Rac1* ^*SHF*^ *;mT/mG*) mice. The *mT/mG* mice possess *loxP* sites on either side of the membrane‐targeted Tomato (mT) cassette with a membrane‐targeted green fluorescent protein (GFP) cassette downstream. Before *Mef2c‐Cre* mediated excision, mT (red fluorescence) is expressed in all cells. After *Mef2c‐Cre*--mediated excision, the mT cassette is cleaved out, and membrane‐targeted GFP (mG) is expressed in all SHF progenitors and SHF‐derived tissues.

Histological Analysis {#jah31268-sec-0008}
---------------------

Neonatal and embryonic samples were fixed overnight in 4% paraformaldehyde at 4°C, dehydrated, and embedded in paraffin. Embryos were serially sectioned as 5‐μm‐thick sections with a Leica RM2255 microtome, and sections were mounted onto positively charged albumin/glycerin‐coated slides, as described previously.[21](#jah31268-bib-0021){ref-type="ref"} Slides underwent a dewaxing process and were stained with hematoxylin and eosin or picrosirius red for morphological analysis. Images were captured with a Zeiss Observer D1 light microscope.

Immunohistochemistry {#jah31268-sec-0009}
--------------------

For immunohistochemical staining on paraffin sections, samples underwent a deparaffin process, and antigen retrieval was performed in sodium citrate buffer, as described previously.[21](#jah31268-bib-0021){ref-type="ref"} The primary antibodies used for immunostaining included phosphohistone‐H3 (phospho S10; Abcam), GFP (Abcam), α‐actinin (Sigma‐Aldrich), semaphorin 3c (Sema3c; Santa Cruz Biotechnology), and activating enhancer binding protein 2 alpha (AP2α) (Santa Cruz Biotechnology). Slides were then incubated with biotinylated secondary antibody followed by incubation with avidin and biotinylated horseradish peroxidase from the Santa Cruz ImmunoCruz ABC staining system kit. Antigen was visualized with diaminobenzidine substrate solution, and slides were counterstained with hematoxylin. All images were captured with a Zeiss Observer D1 microscope using AxioVision release 4.7 software. For frozen sections, embryos were fixed for 1 hour in 4% paraformaldehyde, cryoprotected in 30% sucrose, and embedded in FSC22 frozen section media (Leica). Embryos were sectioned in a sagittal orientation at 10 μm thick and immunostained with the primary antibodies for Scrib (Santa Cruz Biotechnology), atypical protein kinase C zeta (aPKCζ) (Santa Cruz Biotechnology), and active (nonphosphorylated) β‐catenin (Cell Signaling). Additional staining was also performed with Alexa Fluor 488 phalloidin (Life Technologies), Alexa Fluor 647 wheat germ agglutinin (Invitrogen), and Hoechst 33342 (Invitrogen). A Zeiss LSM 510 Duo microscope with ZEN 2012 software (Zeiss) located at the Biotron Experimental Climate Change Research Center at Western University (London, Ontario, Canada) was used to obtain confocal images.

Intrauterine Echocardiography {#jah31268-sec-0010}
-----------------------------

Echocardiography was performed on pregnant mice using the Vevo 2100 system (VisualSonics).[27](#jah31268-bib-0027){ref-type="ref"} Briefly, pregnant mice were anesthetized with isoflurane, and fur was shaved from the abdomen to better image embryos. A map was drawn of the location of embryos relative to each other to facilitate harvesting of embryos after intrauterine echocardiography. A dynamically focused 40‐MHz probe was used to obtain 2‐dimensional images of embryonic hearts in short‐axis view. Diastolic and systolic left ventricular internal diameters (LVID) were measured from M‐mode recordings. Calculations were performed as followed: EF(%)=\[(LVIDd)^3^−(LVIDs)^3^\]/(LVIDd)^3^×100 and FS(%)=(LVIDd−LVIDs)/LVIDd×100. EF indicates ejection fraction, d indicates diastolic, s indicates systolic, and FS indicates fractional shortening.

Statistical Analysis {#jah31268-sec-0011}
--------------------

All data are presented as median and interquartile range. Because the sample size was 4 to 8 per group and was not normally distributed, a nonparametric Mann--Whitney test was performed to compare the difference between the 2 groups. A 2‐tailed *P* value \<0.05 was considered statistically significant.

Results {#jah31268-sec-0012}
=======

Early Defects in the Splanchnic Mesoderm of *Rac1* ^*SHF*^ {#jah31268-sec-0013}
----------------------------------------------------------

Lineage tracing analysis using *Mef2c‐Cre* and *mT/mG* global double‐fluorescent reporter mice revealed that lack of Rac1 in the anterior SHF resulted in defects in splanchnic mesoderm at E9.5. Large acellular spaces were observed between GFP^+^ SHF progenitor cells, and fewer cells resided in the overall splanchnic mesoderm region of E9.5 *Rac1* ^*SHF*^ *;mTmG* embryos (Figure [1](#jah31268-fig-0001){ref-type="fig"}C and [1](#jah31268-fig-0001){ref-type="fig"}D) compared with littermate *Mef2c‐Cre;mTmG;Rac1* ^*f/+*^ controls (Figure [1](#jah31268-fig-0001){ref-type="fig"}A and [1](#jah31268-fig-0001){ref-type="fig"}B). The number of GFP^+^ SHF progenitor cells in the splanchnic mesoderm was significantly less in *Rac1* ^*SHF*^ embryos compared with controls (Figure [1](#jah31268-fig-0001){ref-type="fig"}E). Before differentiation, the SHF progenitor population in the splanchnic mesoderm is highly proliferative.[28](#jah31268-bib-0028){ref-type="ref"} To analyze SHF proliferation, phosphohistone‐H3 immunostaining was performed on sagittal sections of E9.5 embryos (Figure [1](#jah31268-fig-0001){ref-type="fig"}F and [1](#jah31268-fig-0001){ref-type="fig"}G). The proliferation rate of SHF progenitors in E9.5 *Rac1* ^*SHF*^ was significantly reduced compared with littermate *Rac1* ^*f/f*^ controls (Figure [1](#jah31268-fig-0001){ref-type="fig"}H). This reduced proliferation rate likely resulted in a reduced number of SHF progenitors within the *Rac1* ^*SHF*^ splanchnic mesoderm. These results define a requirement for Rac1 signaling in SHF progenitor cell proliferation.

![Early defects in embryonic day 9.5 (E9.5) *Rac1* ^*SHF*^ splanchnic mesoderm. Lineage tracing with *Mef2c‐Cre;mT/mG* showed a decreased number of GFP ^+^ SHF cells along with large acellular spaces in the splanchnic mesoderm of *Rac1* ^*SHF*^ *;mT/mG* (C and D) compared with littermate control embryos (A and B). The number of GFP ^+^ SHF progenitor cells in the splanchnic mesoderm was significantly reduced in E9.5 *Rac1* ^*SHF*^ *;mT/mG* compared with controls (E). n=4 embryos per group. Immunostaining for pHH3 in the splanchnic mesoderm (F and G) showed a reduced proliferation rate in *Rac1* ^*SHF*^ SHF progenitors compared to *Rac1* ^*f/f*^ controls (H). n=4 (*Rac1* ^*SHF*^) and n=5 (*Rac1* ^*f/f*^) embryos. Scale bars: 100 μm (A and C), 10 μm (B and D), 20 μm (F and G). \**P*\<0.05 by Mann--Whitney test. GFP indicates green fluorescent protein; IFT, inflow tract; OFT, outflow tract; pHH3, phosphohistone H3; SHF, second heart field; SpM, splanchnic mesoderm.](JAH3-5-e002508-g001){#jah31268-fig-0001}

Disruption of Cell Shape and Organization in *Rac1* ^*SHF*^ Splanchnic Mesoderm {#jah31268-sec-0014}
-------------------------------------------------------------------------------

SHF progenitor cells possess apicobasal polarity that forms a polarized epithelial layer in the dorsal pericardial wall.[10](#jah31268-bib-0010){ref-type="ref"} Our data show that cellular organization was severely disrupted in the E9.5 *Rac1* ^*SHF*^ anterior SHF progenitors (Figure [2](#jah31268-fig-0002){ref-type="fig"}). The basolateral and apical domains of the *Rac1* ^*f/f*^ splanchnic mesoderm were marked by Scribble and aPKCζ, respectively. In addition, the SHF progenitors have a cuboidal shape, with neighboring cells aligned with one another to form the epithelial layer (Figure [2](#jah31268-fig-0002){ref-type="fig"}A through [2](#jah31268-fig-0002){ref-type="fig"}C). In comparison, organization of the *Rac1* ^*SHF*^ SHF epithelial layer was lost, and SHF progenitor cells exhibited a rounded morphology. Cellular organization in the E9.5 *Rac1* ^*SHF*^ splanchnic mesoderm was disturbed where the basal domains of neighboring SHF progenitors were no longer aligned with one another, and the cells displayed a rounded morphology (Figure [2](#jah31268-fig-0002){ref-type="fig"}D through [2](#jah31268-fig-0002){ref-type="fig"}F). Orientation of the long axis of the anterior SHF progenitor cells were measured relative to the axis of the dorsal pericardial wall (Figure [2](#jah31268-fig-0002){ref-type="fig"}G), and it was found that E9.5 *Rac1* ^*SHF*^ SHF progenitor cells had a random, unorganized orientation compared with *Rac1* ^*f/f*^ controls. *Rac1* ^*f/f*^ SHF progenitors had an orientation range of 62° to 89.5°, averaging 78.5° relative to the dorsal pericardial wall axis. In comparison, *Rac1* ^*SHF*^ SHF progenitors oriented with a significantly smaller angle averaging 41.8° relative to the dorsal pericardial wall axis (Figure [2](#jah31268-fig-0002){ref-type="fig"}H). Cell--cell junctions, as marked by active (nonphosphorylated) β‐catenin expression, were disrupted in the E9.5 *Rac1* ^*SHF*^ splanchnic mesoderm compared with *Rac1* ^*f/f*^ controls, further supporting a disruption in SHF progenitor cell organization (Figure [2](#jah31268-fig-0002){ref-type="fig"}I and [2](#jah31268-fig-0002){ref-type="fig"}J). Taken together, these findings support a critical role of Rac1 signaling in regulation of overall SHF progenitor cell shape and maintenance of cell organization.

![Disrupted apicobasal cell polarity and orientation in *Rac1* ^*SHF*^ splanchnic mesoderm. A and B, In embryonic day 9.5 (E9.5) *Rac1* ^*f/f*^ SHF progenitors, the basolateral domain is marked by Scribble (B, arrows), and the apical domain is marked by aPKCζ (A, arrowheads). The SHF progenitors have a distinct cuboidal shape, forming an organized epithelial layer (C). Polarity is disrupted in *Rac1* ^*SHF*^ SHF progenitors in which the Scribble‐positive basal domains (E, arrows) and aPKCζ‐positive apical domains (D, arrowheads) of individual cells are no longer aligned with neighboring cells due to the rounded morphology of the SHF progenitors (F). C, Overlay of panels A and B. F, Overlay of panels D and E. The angle of the E9.5 SHF progenitor cell long axis (dashed line) was measured relative to the axis of the dorsal pericardial wall (dashed arrow line) to obtain the degree of orientation (G). Images in panel G are from panels C and F with an overlay of schematic axis and angle measurements. H, The angle of each SHF progenitor cell in the splanchnic mesoderm was measured and plotted. \**P*\<0.05 by Mann--Whitney test, n=4 embryos per group. Each data point represents 1 SHF progenitor cell. Active (nonphosphorylated) β‐catenin marked cell--cell junctions in E9.5 *Rac1* ^*f/f*^ SHF progenitors (I, arrows). In comparison, cell--cell junctions were disrupted in E9.5 *Rac1* ^*SHF*^ SHF progenitors (J). Scale bars: 10 μm (A through F, I and J). SHF indicates second heart field.](JAH3-5-e002508-g002){#jah31268-fig-0002}

Loss of Rac1 in the SHF Results in Shortened OFT and Myocardial Defects of the OFT {#jah31268-sec-0015}
----------------------------------------------------------------------------------

Sufficient lengthening of the heart tube from SHF progenitors ensures convergence of the inflow and outflow poles during cardiac looping. A shortened OFT alters looping and leads to arterial pole misalignment defects such as double‐outlet right ventricle and overriding aorta.[29](#jah31268-bib-0029){ref-type="ref"}, [30](#jah31268-bib-0030){ref-type="ref"} The sagittal length of the OFT was measured at E10.5 (Figure [3](#jah31268-fig-0003){ref-type="fig"}A and [3](#jah31268-fig-0003){ref-type="fig"}B), and it was found that the *Rac1* ^*SHF*^ OFT was significantly shorter compared with controls (Figure [3](#jah31268-fig-0003){ref-type="fig"}C). Closer analysis of the SHF‐derived OFT myocardium revealed a disorganized myocardial layer in E10.5 *Rac1* ^*SHF*^ OFT compared with controls (Figure [3](#jah31268-fig-0003){ref-type="fig"}D through [3](#jah31268-fig-0003){ref-type="fig"}G). Myocardial cells in the *Rac1* ^*f/f*^ OFT were aligned with one another and had a general oval or cuboidal cell shape (Figure [3](#jah31268-fig-0003){ref-type="fig"}D and [3](#jah31268-fig-0003){ref-type="fig"}F). In contrast, myocardial cells in the *Rac1* ^*SHF*^ OFT were not as well organized, and the shapes of the cells were not as distinctly oval or cuboidal (Figure [3](#jah31268-fig-0003){ref-type="fig"}E and [3](#jah31268-fig-0003){ref-type="fig"}G). In addition, cell--cell adhesion junction marked by β‐catenin was generally disrupted in the myocardium of E10.5 *Rac1* ^*SHF*^ OFT compared with *Rac1* ^*f/f*^ controls (Figure [3](#jah31268-fig-0003){ref-type="fig"}H and [3](#jah31268-fig-0003){ref-type="fig"}I). These results suggest an important role of Rac1 in generating the cellular organization of the myocardial layer and lengthening of the OFT.

![Defects in early *Rac1* ^*SHF*^ outflow tract development. A through C, Length of the OFT at embryonic day 10.5 (E10.5) was measured in sagittal sections (A and B) and was found to be significantly shorter in *Rac1* ^*SHF*^ compared with *Rac1* ^*f/f*^ controls (C). ^*\**^ *P*\<0.05 by Mann--Whitney test, n=4 (*Rac1* ^*SHF*^) and n=5 (*Rac1* ^*f/f*^) embryos. D and E, WGA staining to mark cell membranes of SHF cells in the OFT at E10.5 show a disorganized myocardial layer in *Rac1* ^*SHF*^ compared with *Rac1* ^*f/f*^ littermate controls. F and G, Schematic diagrams of panels D and E, respectively. H and I, Active (nonphosphorylated) β‐catenin staining is reduced at cell--cell junctions in E10.5 *Rac1* ^*SHF*^ OFT myocardial cells. White arrows indicate cell--cell adhesion sites. Dotted white lines indicate boundaries of the OFT myocardial layer in panels D, E H, and I. Scale bars: 100 μm (A and B), 10 μm (D, E, H, and I). IFT indicates inflow tract; myo indicates myocardium; OFT, outflow tract; SHF, second heart field; WGA, wheat germ agglutinin.](JAH3-5-e002508-g003){#jah31268-fig-0003}

OFT Defects in *Rac1* ^*SHF*^ Hearts {#jah31268-sec-0016}
------------------------------------

Examination of *Rac1* ^*SHF*^ hearts revealed a spectrum of OFT defects from E14.5 to postnatal day 0 (P0) that was 100% penetrant (Table [1](#jah31268-tbl-0001){ref-type="table-wrap"}). The majority of the defects found were OFT alignment defects. More than one‐third of *Rac1* ^*SHF*^ hearts (23 of 64) displayed a double‐outlet right ventricle (Figure [4](#jah31268-fig-0004){ref-type="fig"}A through [4](#jah31268-fig-0004){ref-type="fig"}D), and more than another third (24 of 64) exhibited an overriding aorta (Figure [4](#jah31268-fig-0004){ref-type="fig"}E and [4](#jah31268-fig-0004){ref-type="fig"}F). Transposition of the great arteries was found in 1 P0 *Rac1* ^*SHF*^ sample (Figure [4](#jah31268-fig-0004){ref-type="fig"}G and [4](#jah31268-fig-0004){ref-type="fig"}H). In addition to defects in OFT alignment, defects in septation of the OFT resulting in persistent truncus arteriosis or common arterial trunk was observed in 9.4% (6 of 64) of *Rac1* ^*SHF*^ hearts (Figure [4](#jah31268-fig-0004){ref-type="fig"}I and [4](#jah31268-fig-0004){ref-type="fig"}J). Narrowing of the great arteries was also observed in *Rac1* ^*SHF*^ hearts including stenosis of the pulmonary artery (Figure [4](#jah31268-fig-0004){ref-type="fig"}K and [4](#jah31268-fig-0004){ref-type="fig"}L) and aortic atresia (Figure [4](#jah31268-fig-0004){ref-type="fig"}M and [4](#jah31268-fig-0004){ref-type="fig"}N). In 1 case of aortic atresia in *Rac1* ^*SHF*^ hearts, aortic valves were also severely malformed (Figure [4](#jah31268-fig-0004){ref-type="fig"}O and [4](#jah31268-fig-0004){ref-type="fig"}P). In addition, we observed abnormalities in aortic arch artery remodeling resulting in a retroesophageal right subclavian artery or a vascular ring, a congenital defect in which vascular structures surround and constrict the esophagus and trachea. This was evident in 18.8% (12 of 64) of *Rac1* ^*SHF*^ hearts, and of the 12 samples that had a vascular ring, 3 had a right‐sided aortic arch (Figure [5](#jah31268-fig-0005){ref-type="fig"}A through [5](#jah31268-fig-0005){ref-type="fig"}F and Videos S1 and S2). Taken together, these data strongly support a critical requirement for Rac1 signaling in anterior SHF progenitors for normal OFT morphogenesis.

###### 

Outflow Tract Defects in *Rac1* ^*SHF*^ Hearts (E14.5‐P0)

         TGA   PTA   DORV   Overriding Aorta   Aortic Atresia   Vascular Ring
  ------ ----- ----- ------ ------------------ ---------------- ---------------
  n=64   1     6     23     32                 5                12
  \%     1.6   9.4   35.9   50                 7.8              18.8

All 64 *Rac1* ^*SHF*^ hearts had ≥1 OFT defect. No OFT defects were found in *Rac1* ^*f/f*^ hearts (n=36). DORV indicates double‐outlet right ventricle; PTA, persistent truncus arteriosus; TGA, transposition of great arteries.

![Spectrum of OFT defects found in E14.5‐P0 *Rac1* ^*SHF*^ hearts. Double‐outlet right ventricle was found in E15.5 *Rac1* ^*SHF*^ hearts (A through D). The PA connects to the RV in both *Rac1* ^*SHF*^ and *Rac1* ^*f/f*^ hearts (A and B). The *Rac1* ^*SHF*^ Ao (arrow) incorrectly connects to the RV compared with *Rac1* ^*f/f*^ controls, in which the Ao connects to the LV (C and D). Overriding Ao, in which the Ao is positioned directly over a ventricular septal defect (arrow), was observed in *Rac1* ^*SHF*^ hearts (E and F). Transposition of the great arteries was found in 1 *Rac1* ^*SHF*^ sample in which the Ao and PA openings were switched, which resulted in the Ao connecting to the RV in *Rac1* ^*SHF*^ and the PA connecting to the LV (G and H), respectively. PTA, in which the common OFT is not divided into aorta and pulmonary, was observed in *Rac1* ^*SHF*^ hearts (I and J). Stenosis of the PA was observed in *Rac1* ^*SHF*^ hearts (K and L). Aortic atresia was observed in *Rac1* ^*SHF*^ hearts (M and N), and in 1 sample with aortic atresia, distinct aortic valves were absent (O and P). Scale bars: 100 μm. Ao indicates aorta; E, embryonic day; LA, left atrium; LV, left ventricle; OFT, outflow tract; PA, pulmonary artery; PTA, persistent truncus arteriosus; RA, right atrium; RV, right ventricle; SHF, second heart field.](JAH3-5-e002508-g004){#jah31268-fig-0004}

![Vascular rings in embryonic day 15.5 *Rac1* ^*SHF*^ hearts. A right‐sided AA was observed in *Rac1* ^*SHF*^ (D) hearts compared with *Rac1* ^*f/f*^ controls (A). An aberrant retroesophageal right SCA, which arose from AA, was observed next to the Tr and Eo in *Rac1* ^*SHF*^ hearts (E) compared with *Rac1* ^*f/f*^ controls (B). The SCA in *Rac1* ^*SHF*^ hearts joined with the PA, forming a vascular ring (F) in *Rac1* ^*SHF*^ hearts compared with controls (C). Scale bars: 100 μm. AA indicates aortic arch; Ao, aorta; DA, dorsal aorta; Eo, esophagus; PA, pulmonary artery; SCA, subclavian artery; Tr, trachea.](JAH3-5-e002508-g005){#jah31268-fig-0005}

Myocardialization Defects in *Rac1* ^*SHF*^ Hearts {#jah31268-sec-0017}
--------------------------------------------------

Myocardialization is a process in which myocardial cells migrate and grow into the flanking mesenchyme. At E12, myocardial cells of the OFT begin to invade the neighboring cushion mesenchyme. This leads to a gradual replacement of the mesenchymal tissue with myocardium to form the muscular outlet septum by E17.[31](#jah31268-bib-0031){ref-type="ref"} Abnormalities in muscularization of the OFT cushions was observed in E12.5 *Rac1* ^*SHF*^ hearts. The *Rac1* ^*SHF*^ OFT myocardium lacked a polarized morphology and did not extend as far into the cushion mesenchyme compared with controls (Figure [6](#jah31268-fig-0006){ref-type="fig"}A and [6](#jah31268-fig-0006){ref-type="fig"}B). Muscularization of the proximal OFT septum is complete in P0 *Rac1* ^*f/f*^ control hearts, as shown by α‐actinin--positive muscle tissue separating the aorta from the right ventricle (Figure [6](#jah31268-fig-0006){ref-type="fig"}C). In P0 *Rac1* ^*SHF*^ hearts, the proximal OFT septum remained nonmuscularized, and remnant collagen‐rich mesenchymal tissue remained (Figure [6](#jah31268-fig-0006){ref-type="fig"}D), staining positive for picrosirius red (Figure [6](#jah31268-fig-0006){ref-type="fig"}E and [6](#jah31268-fig-0006){ref-type="fig"}F). *Rac1* ^*SHF*^ samples with defects in muscularization of the proximal OFT septum also presented with OFT misalignment defects including overriding aorta and double‐outlet right ventricles. These results further support a crucial role for Rac1 signaling in regulating polarity, along with elongation and migration of cardiomyocytes during the process of OFT myocardialization.

![Abnormalities in *Rac1* ^*SHF*^ OFT myocardialization. E12.5 *Rac1* ^*SHF*^ OFT cardiomyocytes, marked by α‐actinin immunostaining (B), exhibited a blunted morphology instead of a polarized morphology and did not extend as far into the OFT cushions compared with controls (A). Red arrows indicate invading cardiomyocytes. The proximal OFT septum remained nonmuscularized in P0 *Rac1* ^*SHF*^ hearts (D), indicated by an absence of α‐actinin staining (arrows in D) compared with control (C), in which the septum is muscularized (arrow in C). The nonmuscularized proximal OFT septum in *Rac1* ^*SHF*^ hearts (F) stained positive for picrosirius red (arrows in F), indicating that this tissue remained mesenchymal compared with controls (E), which had become muscularized (arrow in E). n=3 for each staining per group. Scale bars: 10 μm (A and B), 50 μm (C through F). Ao indicates aorta; E, embryonic day; OFT, outflow tract; RV, right ventricle; SHF, second heart field.](JAH3-5-e002508-g006){#jah31268-fig-0006}

Decreased Cardiac Neural Crest Cell Migration in *Rac1* ^*SHF*^ {#jah31268-sec-0018}
---------------------------------------------------------------

The aortic arch artery and OFT septation defects observed in *Rac1* ^*SHF*^ hearts suggest abnormal formation or remodeling of the arteries involving cardiac neural crest cells. Sema3c is a secreted glycoprotein part of the semaphorin protein family, which plays a role in axon guidance.[32](#jah31268-bib-0032){ref-type="ref"} Sema3c is expressed in the OFT myocardium and acts as a chemoattractant, navigating neural crest cells to the OFT. Neural crest cells express the multimeric complexes of plexins and neuropilin, which are the receptors that recognize semaphorin ligands.[33](#jah31268-bib-0033){ref-type="ref"} Interactions between SHF progenitors and cardiac neural crest cells have been shown to be critical for development of the aortic arches and semilunar valves.[6](#jah31268-bib-0006){ref-type="ref"}, [7](#jah31268-bib-0007){ref-type="ref"} Sema3c expression was analyzed in *Rac1* ^*SHF*^ hearts, and intensity of Sema3c protein staining in E11.5 *Rac1* ^*SHF*^ OFT myocardium was found to be decreased compared with *Rac1* ^*f/f*^ controls (Figure [7](#jah31268-fig-0007){ref-type="fig"}C, [7](#jah31268-fig-0007){ref-type="fig"}D, and [7](#jah31268-fig-0007){ref-type="fig"}F). Along with this, the mRNA level of Sema3c, as measured by real‐time polymerase chain reaction, was significantly reduced in *Rac1* ^*SHF*^ hearts compared with littermate controls at E13.5 (Figure [7](#jah31268-fig-0007){ref-type="fig"}G). Consequently, this would be predicted to result in a reduction in the chemoattractant signal attracting the migrating neural crest cells into the developing heart. The number of migrating cardiac neural crest cells, marked by the transcription factor AP2α, was significantly decreased in the region between the foregut and pericardial cavity in E10.5 *Rac1* ^*SHF*^ embryos (Figure [7](#jah31268-fig-0007){ref-type="fig"}A, [7](#jah31268-fig-0007){ref-type="fig"}B, and [7](#jah31268-fig-0007){ref-type="fig"}E). These results suggest that disruption of Rac1 signaling in the SHF‐derived OFT myocardium leads to reduced expression of axonal guidance signals that attract migrating neural crest cells into the developing OFT.

![Defects in neural crest cell contribution to OFT development in *Rac1* ^*SHF*^ hearts. A and B, AP2α immunostaining was performed to mark neural crest cells in the pharyngeal region of embryonic day 10.5 (E10.5) samples. C and D, Sema3c immunostaining (brown color) in *Rac1* ^*SHF*^ and *Rac1* ^*f/f*^ OFT myocardium at E11.5. E, The number of neural crest cells was significantly reduced in E10.5 *Rac1* ^*SHF*^ pharyngeal arches compared with controls. F, Intensity of Sema3c staining in the E11.5 OFT myocardium was ranked on a scale from 1 to 5. Overall intensity of Sema3c staining was reduced in *Rac1* ^*SHF*^ compared with *Rac1* ^*f/f*^ controls. G, The level of *Sema3c* mRNA in *Rac1* ^*SHF*^ hearts at E13.5 was significantly reduced compared with controls. ^*\**^ *P*\<0.05 Mann--Whitney test. n=4 to 5 hearts (E and F) and n=7 to 8 hearts (G) per group. Scale bars: 20 μm (A and B), 10 μm (C and D). FG indicates foregut; OFT, outflow tract; PC, pericardial cavity; Sema3c, semaphorin 3c; SHF, second heart field.](JAH3-5-e002508-g007){#jah31268-fig-0007}

Aortic Valve Defects in *Rac1* ^*SHF*^ Hearts {#jah31268-sec-0019}
---------------------------------------------

Formation of valves involves a complex process of cushion formation, elongation, valve remodeling, and maturation.[34](#jah31268-bib-0034){ref-type="ref"} Both SHF progenitors and cardiac neural crest cells contribute to aortic valve development. Neural crest cells are known to be involved in late gestation remodeling and maturation of the aortic valves.[7](#jah31268-bib-0007){ref-type="ref"}, [8](#jah31268-bib-0008){ref-type="ref"} We predicted that the decreased number of migrated cardiac neural crest cells into *Rac1* ^*SHF*^ hearts would also affect development of *Rac1* ^*SHF*^aortic valves. P0 *Rac1* ^*SHF*^ heart sections were analyzed and found to have large, thickened aortic valve leaflets compared with controls that, in contrast, had undergone remodeling and matured into thin, elongated leaflets (Figure [8](#jah31268-fig-0008){ref-type="fig"}A and [8](#jah31268-fig-0008){ref-type="fig"}B). Cell density of the aortic valve leaflets was also significantly decreased in P0 *Rac1* ^*SHF*^ hearts compared with P0 *Rac1* ^*f/f*^ hearts (14.3±1.0 versus 17.8±0.8 cells/1000 μm^2^, *P*\<0.05, n=5--7), suggesting defects in extracellular matrix remodeling, which is necessary for the dense packing of cells in the elongating valves.

![Aortic valve defects in P0 *Rac1* ^*SHF*^ hearts. More than 30% (9 of 28) of P0 *Rac1* ^*SHF*^ hearts exhibited thick aortic valve leaflets (B) compared with the thin, remodeled valves of controls (A). Toluidine blue staining showed that GAG (light purple color) occupies the acellular space of *Rac1* ^*SHF*^ and littermate valve leaflets (C and D). Masson\'s trichrome staining in *Rac1* ^*f/f*^ aortic valves showed collagen in the commissure of valve leaflets (E, arrows), which was absent in *Rac1* ^*SHF*^ aortic valves (F, arrows). The GAG‐positive area (light purple color) in each valve leaflet (C and D) was quantified in (G). *\*\*P*\<0.01 by Mann--Whitney test, n=5 to 6 hearts per group. Scale bars: 100 μm (A through D), 10 μm (E and F). Ao indicates aorta; GAG, glycosaminoglycans; LCC, left coronary cusp; NCC, noncoronary cusp; RCC, right coronary cusp; SHF, second heart field.](JAH3-5-e002508-g008){#jah31268-fig-0008}

To assess glycosaminoglycans, a component of extracellular matrix in the aortic valve, toluidine blue staining was performed.[35](#jah31268-bib-0035){ref-type="ref"} The acellular space of the valve leaflets stained light purple, indicating the presence of glycosaminoglycans (Figure [8](#jah31268-fig-0008){ref-type="fig"}C and [8](#jah31268-fig-0008){ref-type="fig"}D). Notably, a significantly larger amount of glycosaminoglycans was present in *Rac1* ^*SHF*^ aortic valves compared with littermate *Rac1* ^*f/f*^ controls at P0 (*P*\<0.01) (Figure [8](#jah31268-fig-0008){ref-type="fig"}G).

During the early stages of development, there is little to no collagen present in the semilunar valves. As the valves mature, collagen content increases, especially at the commissure of the valves.[36](#jah31268-bib-0036){ref-type="ref"} Analysis of P0 *Rac1* ^*f/f*^ aortic valves after Masson\'s trichrome staining revealed early signs of maturation, with collagen present at the valve commissure (Figure [8](#jah31268-fig-0008){ref-type="fig"}E). In comparison, P0 *Rac1* ^*SHF*^ aortic valves were less mature and had little to no collagen present at the valve commissure (Figure [8](#jah31268-fig-0008){ref-type="fig"}F).

Lineage tracing with *mT/mG* at E12.5 revealed decreased SHF progenitor contribution to the OFT cushions in *Rac1* ^*SHF*^ hearts compared with control hearts, which had numerous SHF‐derived GFP^+^ cells in the cushion mesenchyme (Figure [9](#jah31268-fig-0009){ref-type="fig"}A and [9](#jah31268-fig-0009){ref-type="fig"}B, black arrows). At E14.5, SHF contribution to the aortic valve leaflets continued to be severely reduced in *Rac1* ^*SHF*^ hearts (Figure [9](#jah31268-fig-0009){ref-type="fig"}C and [9](#jah31268-fig-0009){ref-type="fig"}D, black arrows). In addition, at both E12.5 and E14.5, contribution of SHF progenitors to the *Rac1* ^*SHF*^ OFT myocardium seemed to be decreased compared with controls (Figure [9](#jah31268-fig-0009){ref-type="fig"}A through [9](#jah31268-fig-0009){ref-type="fig"}D, red arrows). This lineage tracing data strongly suggest an overall impairment in overall SHF progenitor cell contribution to the developing heart in *Rac1* ^*SHF*^ embryos and a critical role for SHF Rac1 in maturation and remodeling of the aortic valves.

![Decreased SHF contribution to *Rac1* ^*SHF*^ OFT. Fate mapping with *mT/mG* reporter shows a decreased SHF progenitor contribution to the OFT myocardium (red arrows in B and D) in E12.5 and E14.5 *Rac1* ^*SHF*^ hearts compared with controls (red arrows in A and C). SHF contribution to the valve leaflets was also severely reduced in *Rac1* ^*SHF*^ hearts compared with controls (black arrows, A through D). Paraffin sections were immunostained with anti‐GFP. Scale bars: 20 μm. n=3 for each time point per group. Ao indicates aorta; E, embryonic day; OFT, outflow tract; SHF, second heart field.](JAH3-5-e002508-g009){#jah31268-fig-0009}

Abnormal Aortic Valve Function in *Rac1* ^*SHF*^ Hearts {#jah31268-sec-0020}
-------------------------------------------------------

The observed aortic valve defects would be predicted to result in functional impairment of the valves. To assess the function of the malformed *Rac1* ^*SHF*^ aortic valves, intrauterine echocardiography at E18.5 was performed. Embryos from timed pregnant female mice were analyzed prior to genotyping, and thus echo analysis was performed in a blinded manner. All E18.5 *Rac1* ^*f/f*^ control embryos did not demonstrate any evidence of aortic valve regurgitation (Figure [10](#jah31268-fig-0010){ref-type="fig"}A). In contrast, E18.5 *Rac1* ^*SHF*^ embryos were found to have severe aortic regurgitation during diastole (Figure [10](#jah31268-fig-0010){ref-type="fig"}B). In addition, LVID during systole was significantly increased in *Rac1* ^*SHF*^ hearts, whereas no significant differences were observed in LVID during diastole. Both ejection fraction and fractional shortening in E18.5 *Rac1* ^*SHF*^ embryos were also significantly reduced compared with controls (Table [2](#jah31268-tbl-0002){ref-type="table-wrap"}). Decreased left ventricular function in *Rac1* ^*SHF*^ hearts is likely related to the defects in myocardial development reported in our previous study.[21](#jah31268-bib-0021){ref-type="ref"} These echocardiography data further define a requirement for SHF *Rac1* in development and functional maturation of the aortic valves.

![Aortic valve regurgitation in *Rac1* ^*SHF*^ hearts. Intrauterine echocardiography at embryonic day 18.5 showed that *Rac1* ^*SHF*^ hearts had severe aortic regurgitation during diastole (B, red arrows), which is not observed in *Rac1* ^*f/f*^ littermates (A). White arrows in (A and B) indicate forward blood flow during systole. Shown are representatives of 5 fetuses per group. SHF indicates second heart field.](JAH3-5-e002508-g010){#jah31268-fig-0010}

###### 

Intrauterine Echocardiography in Embryonic Day 18.5 *Rac1* ^*SHF*^ Hearts

                               Rac1^*f/f*^ (n=5)   *Rac1* ^*SHF*^ (n=5)
  ---------------------------- ------------------- ------------------------------------------------------
  Duration of backflow, ms     0 (0)               183 (66)
  Velocity of backflow, mm/s   0 (0)               164 (19)
  LVIDd, mm                    0.90 (0.03)         0.91 (0.18)
  LVIDs, mm                    0.57 (0.06)         0.67 (0.11)[\*](#jah31268-note-0004){ref-type="fn"}
  Ejection fraction (%)        32.5 (4.6)          26.1 (5.7)[\*\*](#jah31268-note-0004){ref-type="fn"}
  Fractional shortening (%)    69.3 (6.0)          59.6 (9.5)[\*\*](#jah31268-note-0004){ref-type="fn"}

LVIDd indicates left ventricular internal diameter in diastole; LVIDs, left ventricular internal diameter in systole.

*\*P*\<0.05, *\*\*P*\<0.01 by unpaired Student *t* test.

Discussion {#jah31268-sec-0021}
==========

Recent studies have established cell and tissue polarity as important regulators of cardiac OFT development, especially factors involved in the planar cell polarity pathway[11](#jah31268-bib-0011){ref-type="ref"}, [12](#jah31268-bib-0012){ref-type="ref"}; however, the role of Rac1 in cardiac OFT development is not clear. In the present study, we demonstrated that a deficiency of Rac1 signaling in the anterior SHF disrupted progenitor cell shape and overall epithelial organization in the splanchnic mesoderm. In addition, the proliferation rate of SHF progenitors was decreased with a loss of Rac1 signaling. Subsequently, as heart development progressed, these early defects in the SHF splanchnic mesoderm resulted in a spectrum of OFT and aortic valve defects. We also showed that Rac1 deficiency disrupted the levels of Sema3c, a chemoattractant for cardiac neural crest cells, generated by the SHF‐derived OFT myocardium, that would provide a mechanism for our observed reduction in migrating neural crest cells observed in the developing OFT (Figure [11](#jah31268-fig-0011){ref-type="fig"}).

![Schematic diagram of midsagittal section of embryonic day 9.5 (E9.5) splanchnic mesoderm. At E9.5, the *Rac1* ^*f/f*^ anterior SHF progenitors in the splanchnic mesoderm are organized into a polarized epithelium (a). Chemotactic signals, such as semaphorin 3c, secreted by the OFT myocardium act as axonal guidance cues for migration of cardiac NC cells from the neural tube (A). In *Rac1* ^*SHF*^embryos, the anterior SHF progenitors are rounded and disorganized, displaying a loss of polarized epithelium characteristics (b). Expression of chemotactic signals is reduced, resulting in decreased migration of neural cells into the OFT (B). NC indicates neural crest; OFT, outflow tract; RA, right atrium; RV, right ventricle; SHF, second heart field.](JAH3-5-e002508-g011){#jah31268-fig-0011}

Intricate signaling cascades exist between the cardiac neural crest and the SHF. Defects in the cardiac neural crests can affect the SHF progenitors and vice versa. Ablation of cardiac neural crest cells led to a failure of the SHF progenitors to lengthen the heart tube and contribute to the OFT myocardium.[30](#jah31268-bib-0030){ref-type="ref"}, [37](#jah31268-bib-0037){ref-type="ref"} In addition to ablation, tissue‐specific genetic deletions in the cardiac neural crest cells, which affect signaling pathways including Bmp and Smad, and in the transcription factor *Tbx3* all have secondary effects on the SHF and result in defects in OFT remodeling, alignment, and elongation.[38](#jah31268-bib-0038){ref-type="ref"}, [39](#jah31268-bib-0039){ref-type="ref"}, [40](#jah31268-bib-0040){ref-type="ref"} Conversely, tissue‐specific genetic deletions in the SHF tissue, including in *Notch* and *Tbx1*, can also have a noncell autonomous effect on migration of cardiac neural crest cells into the developing heart.[7](#jah31268-bib-0007){ref-type="ref"}, [41](#jah31268-bib-0041){ref-type="ref"} Our study showed that conditional deletion of *Rac1* in the SHF reduced the migration of cardiac neural crest cells into the pharyngeal region, suggesting a role for Rac1 in supporting the intercellular signaling that exists between the SHF and neural crest. The mechanism by which Rac1 signaling regulates expression of the neural crest chemoattractant Sema3c in the SHF‐derived OFT myocardium remains to be determined. Studies have shown that Rac1 activates c‐jun N‐terminal kinase (JNK) to increase gene expression, including expression of the zinc‐finger transcription factor *Gata6*.[42](#jah31268-bib-0042){ref-type="ref"}, [43](#jah31268-bib-0043){ref-type="ref"} *Sema3c* can be transcriptionally regulated by Gata6, and in humans, *Gata6* mutations can cause persistent truncus arteriosis through disruptions in the semaphorin--plexin signaling pathway.[44](#jah31268-bib-0044){ref-type="ref"}, [45](#jah31268-bib-0045){ref-type="ref"} Whether this Rac1--JNK--Gata6--semaphorin signaling pathway is conserved in the SHF‐derived OFT myocardium and subsequently signals to the migrating cardiac neural crest during cardiac morphogenesis remains to be determined in future studies.

The OFT defects observed in the *Rac1* ^*SHF*^ embryos in the present study are likely due to a combination of abnormalities in several development events that are linked to initial establishment of cell polarity, including proliferation and migration. First, proliferation of the *Rac1* ^*SHF*^ SHF progenitors in the splanchnic mesoderm is dramatically reduced, decreasing the overall number of anterior SHF cells contributing to OFT development. The two biological processes of cell polarity and proliferation are coordinated during development, during which the polarized state of a progenitor affects its proliferation rate. This linkage has been clearly observed in development of the nervous system.[46](#jah31268-bib-0046){ref-type="ref"}, [47](#jah31268-bib-0047){ref-type="ref"} In this study, we showed that a deficiency of Rac1 signaling in the anterior SHF progenitors resulted in a loss of cellular organization and is correlated with a decrease in proliferation rate, further supporting a link between these two developmental processes. Francou et al has also demonstrated a correlation with direct alteration of the epithelial properties of the anterior SHF progenitors, resulting in reduced progenitor proliferation rate and ectopic differentiation of the SHF progenitor cells[10](#jah31268-bib-0010){ref-type="ref"}; however, the direct mechanistic link between proliferation and cell polarity in the SHF progenitors remains unclear. In neural progenitors, apically localized aPKCζ attenuates the activity of p27Xic1, which is an inhibitor of cyclin‐dependent kinase‐2 (Cdk2). This leads to increased Cdk2 activity and shortening of the G1 and S phases, increasing the rate of proliferation.[48](#jah31268-bib-0048){ref-type="ref"} Whether a similar mechanism exists in anterior SHF progenitors remains to be determined. Furthermore, concomitant to a decrease in SHF progenitor cell proliferation, a decreased migratory ability of the *Rac1* ^*SHF*^ anterior SHF progenitors to add to the arterial pole of the heart tube likely contributed to the observed OFT defects. Establishment of cell polarity is intrinsically linked to migratory ability. Both polarization and migration are events dependent on dynamic changes to the actin cytoskeleton, which is regulated by Rac1.[49](#jah31268-bib-0049){ref-type="ref"} Evidence of impaired migratory ability of the *Rac1* ^*SHF*^ SHF during heart development was recently demonstrated in our previous study.[21](#jah31268-bib-0021){ref-type="ref"} Migration defects were also observed in the present study based on *mT/mG* lineage tracing, which showed reduced contribution of SHF cells to the aortic valves and OFT and impaired migration of cardiomyocytes into the *Rac1* ^*SHF*^ proximal outlet septum during the myocardialization process. These observations support establishment of SHF progenitor epithelial organization as critical to the developmental process.

Valve remodeling and development is regulated by coordinated actions between matrix metalloproteinase and a disintegrin and metalloproteinase with thrombospondin motifs families of zinc metalloproteinases.[50](#jah31268-bib-0050){ref-type="ref"} Studies have shown a role for Rac1 in the regulation of extracellular matrix degradation along with matrix metalloproteinase expression and activity.[51](#jah31268-bib-0051){ref-type="ref"}, [52](#jah31268-bib-0052){ref-type="ref"} The thickened *Rac1* ^*SHF*^ aortic valve leaflets along with decreased valve cell density and increased deposition of glycosaminoglacans observed in this study strongly suggest defects in valvular extracellular matrix degradation and remodeling. Whether Rac1 signaling in the SHF‐derived cells residing in the aortic valve leaflets also regulate the extracellular matrix through matrix metalloproteinases remains to be determined in future studies. Along with this, blood flow--induced hemodynamics can influence valve morphogenetic cues.[53](#jah31268-bib-0053){ref-type="ref"} Our previous study reported atrial and ventricular septal defects along with abnormalities in development of the ventricles in *Rac1* ^*SHF*^ hearts.[21](#jah31268-bib-0021){ref-type="ref"} Whether these structural defects altered the hemodynamic flow and subsequently affected remodeling of the *Rac1* ^*SHF*^ aortic valves remains to be determined.

In summary, our study is the first to show that Rac1 signaling in the anterior SHF is critical to normal cell organization in the splanchnic mesoderm. Loss of Rac1 leads to disruptions in anterior SHF progenitor cellular organization early in development and affects subsequent steps of heart development, including OFT and aortic valve morphogenesis, along with signaling to the neural crest cells. Our study suggests that perturbed Rac1 signaling in the anterior SHF could account for some of the OFT defects observed in humans.
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**Video S1.** Three‐dimensional reconstruction of normal morphology of aortic arch and pulmonary artery in an embryonic day 15.5 *Rac1f/f* heart. In *Rac1f/f* hearts, the aortic arch (pink) is located on the left side. Ascending and descending aorta are in red. The descending aorta runs parallel to the esophagus (green) and trachea (yellow). Pulmonary artery is in blue.
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Click here for additional data file.
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**Video S2.** Three‐dimensional reconstruction of vascular ring in an embryonic day 15.5 *Rac1SHF* heart. In *Rac1SHF* hearts, the aortic arch (pink) is located incorrectly on the right side. The ascending and descending aorta are in red. The descending aorta wraps around the esophagus (green) and trachea (yellow), forming a vascular ring. Pulmonary artery is in blue.
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Click here for additional data file.
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